Proto Labs PRLB Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value at other companies
Other financials
Where this comes from
Reported directly by Proto Labs in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.
The official record: Proto Labs’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Proto Labs's share based compensation arrangement by share based payment award options exercises in period total intrinsic value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Proto Labs's share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
- Proto Labs (PRLB) reported share based compensation arrangement by share based payment award options exercises in period total intrinsic value of $275K in Q4 2025.
- How has Proto Labs's share based compensation arrangement by share based payment award options exercises in period total intrinsic value changed year-over-year?
- Proto Labs's share based compensation arrangement by share based payment award options exercises in period total intrinsic value increased by 1000.0% year-over-year, from $25K to $275K.
- What is the long-term trend for Proto Labs's share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
- Over 4 years (2021 to 2025), Proto Labs's share based compensation arrangement by share based payment award options exercises in period total intrinsic value has grown at a -26.6% compound annual growth rate (CAGR), from $3.8M to $1.1M.
- What does share based compensation arrangement by share based payment award options exercises in period total intrinsic value mean?
- The total difference between the market price of the company's stock and the exercise price of options at the time they were exercised by employees. This represents the realized economic benefit gained by employees from their equity awards. It is a critical component in evaluating the total compensation cost and the alignment of employee incentives with shareholder value.